• Black Instagram Icon

©2019 by TMC Conferences

SPEAKERS

DR BENJAMIN WOOD

PathWest
Perth, Australia
DERMATOPATHOLOGY

A graduate of the University of Newcastle and trained in Anatomical Pathology with the Hunter Area Pathology Service, Dr Wood joined PathWest and the University of Western Australia in 2006. In 2010 he established the PathWest Dermatopathology Group, which now provides a State-Wide public Dermatopathology service in Western Australia, serving all three major teaching hospitals, as well as numerous smaller hospitals and community practitioners.

 

Dr Wood has research interests in melanocytic pathology, cutaneous adnexal tumours and other areas of Dermatopathology. Dr Wood has authored over 100 publications and multiple textbook chapters.  He is a member of the executive committee of the Australian Dermatopathology Society, convenor of the RCPA QAP Dermatopathology Module, examiner for the RCPA post-fellowship Diploma in Dermatopathology and a member of the Western Australian Kirkbride Melanoma Advisory Service panel. 

DR LOUISE JACKETT

Austin Pathology
Melbourne, Australia
DERMATOPATHOLOGY

Following award of her FRCPA, Dr Louise Jackett undertook a fellowship in melanoma pathology at Melanoma Institute Australia and Royal Prince Alfred Hospital in Sydney under the guidance of Prof Richard Scolyer, and was subsequently appointed as a consultant Anatomical Pathologist at Royal Prince Alfred Hospital, before joining Austin Health where she is the principal pathologist overseeing the melanoma consult service.

 

Louise has received world-class training in melanocytic lesions through extensive consultation practice and collaborative research, and has contributed in this field to several international conferences as an invited speaker and as an author of the most recent edition of the WHO Classification of Skin Tumours. She is the current co-convenor of the Dermatopathology session for the Australasian Division of the IAP.

PROF. TERI LONGACRE

Stanford University Medical Center
USA
GYNAECOLOGIC PATHOLOGY

Teri A. Longacre, MD, is a Professor of Pathology and Director of Gynecologic Pathology and Gastrointestinal Pathology at Stanford University, where she has established a clinical research program that is focused on gynae and GI pathology with an emphasis on diagnosis and screening of hereditary gynae and GI cancer syndromes.

 

She is a member of the Steering Committee of the Gynecologic Cancer InterGroup Gynecologic Oncology Pathology Working Group, the Education Committee of the California Society of Pathologists, and served on the Test Development and Advisory Committee for Anatomic Pathology for the American Board of Pathology for more than 10 years. She was a member of the 2013 consensus meeting and the editorial working group for the WHO Classification of Tumors of the Female Genital Tract, and has published extensively in international journals, and has authored/co-authored more than 200 peer reviewed manuscripts, book chapters, and invited monographs in gynecologic and GI pathology. She serves on a number of editorial boards, including the American Journal of Surgical Pathology, Modern Pathology, and International Journal of Gynecologic Pathology and is the new Editor for Sternberg’s Diagnostic Surgical Pathology.

DR LYNETTE SHOLL

Brigham and Women's Hospital
USA
PULMONARY AND MOLECULAR PATHOLOGY

Dr. Sholl is an associate pathologist at Brigham and Women’s Hospital in Boston and Associate Professor of Pathology at Harvard Medical School.  She is board certified in anatomic pathology and molecular genetics pathology with an expertise in neoplastic and non-neoplastic lung diseases.  She completed her medical school training at Stanford University School of Medicine, followed by an internship in internal medicine at the Hospital of University of Pennsylvania, AP residency and fellowship training at Brigham and Women’s Hospital, and the molecular genetics pathology fellowship at the Harvard teaching hospitals. 

 

She performs clinical and translational research focusing on the molecular mechanisms of tumorigenesis in lung carcinomas, identification of predictive and prognostic molecular markers in tumor and fibrosing lung diseases, and validation of novel molecular and immunohistochemical tests for genetic characterization of lung cancers in clinical practice.  Dr. Sholl’s responsibilities include serving as the associate medical director of the Center for Advanced Molecular Diagnostics at Brigham and Women’s Hospital and as Chief of the Pulmonary Pathology Service.